Leukemia, other, PediatricsA Phase 3 Trial Investigating Blinatumomab ( NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)Principal Investigator: Nina Kadan-Lottick
Leukemia, Lymphoma, and Myeloma
- Hodgkin's Lymphoma, Lymphoid Leukemia, Non-Hodgkin's LymphomaManaged Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial ReleasePrincipal Investigator: Iris Isufi
- Hodgkin's Lymphoma, Non-Hodgkin's LymphomaLong-Term Follow-Up Study of Clinical Study Subjects Treated with An Autologous T Cell Product Expressing An Antibody-Coupled T-Cell Receptor (ACTR)Principal Investigator: Iris Isufi
- Anus, Bones and Joints, Brain and Nervous System, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Other Hematopoietic, Phase I, Pediatrics, Unknown Sites, Breast, Cervix, Urinary BladderA Phase 1a/1b Study of LY3405105 Administered to Patients with Advanced Solid TumorsPrincipal Investigator: Patricia LoRusso
- Other Hematopoietic, Pediatrics, Non Therapeutic, Sickle Cell DisordersIdentifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell DonorsPrincipal Investigator: Niketa Shah